Your search returned 688 results.

Results
	541.	Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa. [electronic resource] by Matume, Nontokozo D Tebit, Denis M Gray, Laurie R Hammarskjold, Marie-Louise Rekosh, David Bessong, Pascal O Producer: 20190318 In: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	542.	Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice. [electronic resource] by Reuter, S Braken, P Jensen, B Sierra-Aragon, S Oette, M Balduin, M Kaiser, R Häussinger, D Producer: 20100824 In: European journal of medical research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	543.	Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects. [electronic resource] by Mora-Peris, Borja Croucher, Adam Else, Laura J Vera, Jaime H Khoo, Saye Scullard, George Back, David Winston, Alan Producer: 20131126 In: The Journal of antimicrobial chemotherapy vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	544.	Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network. [electronic resource] by Li, Bi-Qing Niu, Bing Chen, Lei Wei, Ze-Jun Huang, Tao Jiang, Min Lu, Jing Zheng, Ming-Yue Kong, Xiang-Yin Cai, Yu-Dong Producer: 20140114 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	545.	In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha. [electronic resource] by Ashokkumar, Manickam Sonawane, Aanand Sperk, Maike Tripathy, Srikanth P Neogi, Ujjwal Hanna, Luke Elizabeth Producer: 20201113 In: Scientific reports vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	546.	Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. [electronic resource] by Reshef, Ran Luger, Selina M Hexner, Elizabeth O Loren, Alison W Frey, Noelle V Nasta, Sunita D Goldstein, Steven C Stadtmauer, Edward A Smith, Jacqueline Bailey, Sarah Mick, Rosemarie Heitjan, Daniel F Emerson, Stephen G Hoxie, James A Vonderheide, Robert H Porter, David L Producer: 20120727 In: The New England journal of medicine vol. 367 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	547.	Maraviroc: a review of its use in the management of CCR5-tropic HIV-1 infection. [electronic resource] by Perry, Caroline M Producer: 20100817 In: Drugs vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	548.	Ineffective central nervous system HIV suppression of once-a-day maraviroc and ritonavir-boosted darunavir dual therapy: four case reports. [electronic resource] by Ahmed, Nadia Okoli, Chinyere Ainsworth, Jonathan Producer: 20160706 In: International journal of STD & AIDS vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	549.	Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2. [electronic resource] by Hardy, W David Gulick, Roy M Mayer, Howard Fätkenheuer, Gerd Nelson, Mark Heera, Jayvant Rajicic, Natasa Goodrich, James Producer: 20111123 In: Journal of acquired immune deficiency syndromes (1999) vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	550.	Maraviroc for previously treated patients with R5 HIV-1 infection. [electronic resource] by Gulick, Roy M Lalezari, Jacob Goodrich, James Clumeck, Nathan DeJesus, Edwin Horban, Andrzej Nadler, Jeffrey Clotet, Bonaventura Karlsson, Anders Wohlfeiler, Michael Montana, John B McHale, Mary Sullivan, John Ridgway, Caroline Felstead, Steve Dunne, Michael W van der Ryst, Elna Mayer, Howard Producer: 20081007 In: The New England journal of medicine vol. 359 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	551.	CCR5 antagonist blocks metastasis of basal breast cancer cells. [electronic resource] by Velasco-Velázquez, Marco Jiao, Xuanmao De La Fuente, Marisol Pestell, Timothy G Ertel, Adam Lisanti, Michael P Pestell, Richard G Producer: 20121029 In: Cancer research vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	552.	SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses. [electronic resource] by Tsibris, Athe M N Pal, Urboshi Schure, Allison L Veazey, Ronald S Kunstman, Kevin J Henrich, Timothy J Klasse, P J Wolinsky, Steven M Kuritzkes, Daniel R Moore, John P Producer: 20120720 In: PloS one vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	553.	Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains. [electronic resource] by Sironi, Francesca Malnati, Mauro Mongelli, Nicola Cozzi, Paolo Guzzo, Christina Ghezzi, Silvia Martínez-Romero, Carles García-Sastre, Adolfo Lusso, Paolo Jabes, Daniela Biswas, Priscilla Producer: 20160119 In: Journal of translational medicine vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	554.	Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model. [electronic resource] by Yuan, Jing Ren, Han-yun Shi, Yong-jin Liu, Wei Producer: 20150917 In: Inflammation research : official journal of the European Histamine Research Society ... [et al.] vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	555.	Virologic response, early HIV-1 decay, and maraviroc pharmacokinetics with the nucleos(t)ide-free regimen of maraviroc plus darunavir/ritonavir in a pilot study. [electronic resource] by Taiwo, Babafemi Acosta, Edward P Ryscavage, Patrick Berzins, Baiba Lu, Darlene Lalezari, Jay Castro, Jose Adeyemi, Oluwatoyin Kuritzkes, Daniel R Eron, Joseph J Tsibris, Athe Swindells, Susan Producer: 20131113 In: Journal of acquired immune deficiency syndromes (1999) vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	556.	The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1. [electronic resource] by López-Huertas, María Rosa Jiménez-Tormo, Laura Madrid-Elena, Nadia Gutiérrez, Carolina Rodríguez-Mora, Sara Coiras, Mayte Alcamí, José Moreno, Santiago Producer: 20181214 In: Scientific reports vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	557.	Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. [electronic resource] by Pett, S L Amin, J Horban, A Andrade-Villanueva, J Losso, M Porteiro, N Madero, J S Belloso, W Tu, E Silk, D Kelleher, A Harrigan, R Clark, A Sugiura, W Wolff, M Gill, J Gatell, J Clarke, A Ruxrungtham, K Prazuck, T Kaiser, R Woolley, I Alberto Arnaiz, J Cooper, D Rockstroh, J K Mallon, P Emery, S Producer: 20180710 In: HIV medicine vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	558.	Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals. [electronic resource] by Stauch, Kelly L Emanuel, Katy Lamberty, Benjamin G Morsey, Brenda Fox, Howard S Producer: 20180720 In: Journal of neurovirology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	559.	Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists. [electronic resource] by Flynn, Jacqueline K Ellenberg, Paula Duncan, Renee Ellett, Anne Zhou, Jingling Sterjovski, Jasminka Cashin, Kieran Borm, Katharina Gray, Lachlan R Lewis, Marilyn Jubb, Becky Westby, Mike Lee, Benhur Lewin, Sharon R Churchill, Melissa Roche, Michael Gorry, Paul R Producer: 20180130 In: AIDS research and human retroviruses vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	560.	CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer. [electronic resource] by Pervaiz, Asim Zepp, Michael Mahmood, Saqib Ali, Doaa Mohamed Berger, Martin R Adwan, Hassan Producer: 20190527 In: Cellular oncology (Dordrecht, Netherlands) vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 688 results.